tanshinone has been researched along with Cardiomyopathies, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Zheng, M; Zhou, Y; Zhu, J; Zhu, M; Zou, R | 1 |
| Cao, F; Li, J; Li, W; Shen, M; Sun, D; Wang, H; Yuan, Y; Zhang, Y; Zhang, Z; Zhao, L | 1 |
2 other study(ies) available for tanshinone and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis in mice through inhibition of NADPH oxidase.
Topics: Abietanes; Acetophenones; Animals; Cardiomyopathies; Fibrosis; Lipopolysaccharides; Male; Mice, Inbred C57BL; Myocardium; NADPH Oxidase 2; Phosphoproteins; Protective Agents; Reactive Oxygen Species | 2018 |
Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.
Topics: Abietanes; Animals; Apoptosis; Bradykinin; Cardiomyopathies; Cardiotonic Agents; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Interleukin-6; Mitochondria, Heart; Myocardial Contraction; Myocardium; NF-kappa B; Peroxidase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Signal Transduction; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2011 |